Auxilium Pharmaceuticals Asks FDA to OK Xiaflex

Auxilium Pharmaceuticals filed a biologic license application with the Food and Drug Administration seeking marketing approval for Xiaflex, an experimental treatment for Dupuytren’s contracture.
Philadelphia Business Journal